VIENNA, Va.--(BUSINESS WIRE)--$CVM #Multikine--CEL-SCI Corporation (NYSE American: CVM) today announced that the British National Institute for Health and Care Excellence…
VIENNA, Va.--(BUSINESS WIRE)--$CVM #Multikine--CEL-SCI Corporation (NYSE American: CVM) today announced that the British National Institute for Health and Care Excellence…
SEATTLE--(BUSINESS WIRE)--Resurgens Technology Partners, a software-focused private equity firm, today announced its investment in Valant, a cloud-based EHR for behavioral…
SEATTLE--(BUSINESS WIRE)--Resurgens Technology Partners, a software-focused private equity firm, today announced its investment in Valant, a cloud-based EHR for behavioral…
BETHESDA, Md., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the…
Company Achieves NEW Rank Advancements, Acknowledges Sales Directors, and Sets Course for Future ExpansionNAPLES, FL / ACCESSWIRE / December 4,…
Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from…
PARIS, FRANCE / ACCESSWIRE / December 4, 2023 / Spire Healthcare, a leading independent healthcare group in the United Kingdom,…
Ovaprene has the Potential to be the First FDA-Approved Monthly, Self-Administered, Hormone-Free Contraceptive ProductSAN DIEGO, Dec. 04, 2023 (GLOBE NEWSWIRE)…
SAINT LAURENT, Quebec, Dec. 04, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces…